Carisma Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Carisma Therapeutics (CARM) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Carisma Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Carisma Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Carisma Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.9k | 7.0k | 0.27 |
| 2025-06-30 | $8.7k | 22k | 0.39 |
| 2025-03-31 | $951 | 3.1k | 0.31 |
| 2024-12-31 | $10k | 24k | 0.42 |
| 2024-09-30 | $214 | 218 | 0.98 |
| 2024-06-30 | $340 | 224 | 1.52 |
| 2024-03-31 | $62k | 27k | 2.27 |
| 2023-12-31 | $86k | 30k | 2.93 |
| 2023-09-30 | $63k | 15k | 4.23 |
| 2023-06-30 | $135k | 15k | 8.77 |
| 2023-03-31 | $67 | 22 | 3.09 |